All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Orilissa (elagolix) became the latest potential blockbuster to pass FDA scrutiny and the first drug in more than a decade approved to treat moderate to severe pain associated with endometriosis.